Profile data is unavailable for this security.
About the company
Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. It operates in two segments: bioprocess solutions and lab products and services. The bioprocess solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media, single-use bags for cell cultivation and storage of biopharmaceuticals, membrane adsorbers for purification in bioprocesses, filter technology for clarification, among others. The lab Products and Services segment provides instruments, consumables, and services for laboratories, including laboratory balances, laboratory water systems for storage of purified water, electronic pipettes, filter systems for sample preparation, and membrane filter systems for sterility testing of parenteral.
- Revenue in EUR (TTM)3.52bn
- Net income in EUR133.70m
- Incorporated1990
- Employees13.88k
- LocationSartorius AGOtto-Brenner-Str. 20GOETTINGEN 37079GermanyDEU
- Phone+49 5513080
- Fax+49 5 513083289
- Websitehttps://www.sartorius.com/
Mergers & acquisitions
| Acquired company | SRTX:GER since announced | Transaction value |
|---|---|---|
| MatTek Corp | 15.63% | 80.00m |
| Holder | Shares | % Held |
|---|---|---|
| Schroder Investment Management Ltd.as of 31 Dec 2025 | 1.43m | 3.81% |
| T. Rowe Price Associates, Inc. (IM)as of 05 Feb 2026 | 713.40k | 1.91% |
| BlackRock Asset Management Deutschland AGas of 06 Feb 2026 | 554.98k | 1.48% |
| Jennison Associates LLCas of 05 Feb 2026 | 521.91k | 1.39% |
| Union Investment Privatfonds GmbHas of 30 Sep 2025 | 521.54k | 1.39% |
| BlackRock Fund Advisorsas of 06 Feb 2026 | 502.67k | 1.34% |
| Allianz Global Investors GmbHas of 31 Dec 2025 | 493.69k | 1.32% |
| BlackRock Advisors (UK) Ltd.as of 06 Feb 2026 | 397.66k | 1.06% |
| Impax Asset Management Ltd.as of 30 Jan 2026 | 382.52k | 1.02% |
| Blue Whale Capital LLPas of 30 Jun 2025 | 343.68k | 0.92% |
